首页> 外国专利> PREVENTIVE OR THERAPEUTIC POLYEPITOPIC ANTI-TUBERCULOSIS VACCINE CONSTRUCTION PROVIDING INDUCTION OF CELLULAR IMMUNE RESPONSE OF CD4+ OR CD8+ T-LYMPHOCYTES

PREVENTIVE OR THERAPEUTIC POLYEPITOPIC ANTI-TUBERCULOSIS VACCINE CONSTRUCTION PROVIDING INDUCTION OF CELLULAR IMMUNE RESPONSE OF CD4+ OR CD8+ T-LYMPHOCYTES

机译:预防或治疗性多表位抗结核疫苗的构建,可诱导CD4 +或CD8 + T淋巴细胞的细胞免疫反应

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: invention relates to field of genetic engineering, molecular biology and vaccinology. Claimed is polyepitopic anti-tuberculosis vaccine construction for formation of immune response, which provides induction of immune response of CD8+ T-lymphocytes, consisting of universal polyepitopic immunogen, containing CTL-epitopes, selected from immunodominant antigens of M. tuberculosis, fused from N-end with ubiquitin, and having amino acid sequence SEQ ID NO: 1.;EFFECT: vaccine construction provides achievement of effective therapeutic T-cell immune response not only due to antigenspecific cytotoxic CD8+ T-lymphocytes but also intensive response of CD4+ T-lymphocytes.;1 tbl, 11 dwg
机译:技术领域:本发明涉及基因工程,分子生物学和疫苗学领域。要求保护用于形成免疫应答的多表位抗结核疫苗的构建,其提供了CD8 + T淋巴细胞的免疫应答,该CD8 + T淋巴细胞由含有CTL表位的通用多表位免疫原组成,所述表位选自结核分枝杆菌的免疫优势抗原,由N-抗原融合而来。末端具有遍在蛋白,并具有氨基酸序列SEQ ID NO:1。效果:疫苗构建不仅由于抗原特异性的细胞毒性CD8 + T淋巴细胞而且还对CD4 + T淋巴细胞产生强烈应答,从而提供了有效的治疗性T细胞免疫应答。 ; 1 tbl,11 dwg

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号